Please Wait
Applying Filters...
menu
    • menu
    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-06-09

    Virtual Booth

    Contact Supplier

    Menu

    Encorafenib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 21,068Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Pfizer’s Braftovi Combo Halves Death Risk In Colorectal Cancer
    Pfizer’s Braftovi Combo Halves Death Risk In Colorectal Cancer

    30 May 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250530872619/en/Pfizers-BRAFTOVI-Combination-Regimen-Cuts-the-Risk-of-Death-in-Half-for-Patients-with-BRAF-V600E-Mutant-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    30 May 2025
    Share Share
    Pfizer's Vision for Cancer Care at ASCO 2025 Meeting
    Pfizer's Vision for Cancer Care at ASCO 2025 Meeting

    23 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250423613410/en/Pfizer-Advances-Bold-Vision-for-Future-of-Cancer-Care-at-the-ASCO-2025-Annual-Meeting

    BUSINESSWIRE
    23 Apr 2025
    Share Share
    Pfizer angles Braftovi combo for full FDA approval
    Pfizer angles Braftovi combo for full FDA approval

    04 Feb 2025

    // PRESS RELEASE

    https://www.pfizer.com/news/press-release/press-release-detail/pfizers-braftovir-combination-regimen-significantly

    PRESS RELEASE
    04 Feb 2025
    Share Share
    Pfizer’s BRAFTOVI Boosts Response In Mutant Colorectal Cancer
    Pfizer’s BRAFTOVI Boosts Response In Mutant Colorectal Cancer

    27 Jan 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/news/pfizers-braftovi-combination-demonstrates-improved-response-for-mutant-metastatic-colorectal-cancer-16710

    INDPHARMAPOST
    27 Jan 2025
    Share Share
    FDA Approves Pfizer’s Braftovi for 1st-Line Treat Colorectal Cancer
    FDA Approves Pfizer’s Braftovi for 1st-Line Treat Colorectal Cancer

    20 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241210321033/en

    BUSINESSWIRE
    20 Dec 2024
    Share Share
    Pfizer's BRAFTOVI + MEKTOVI Shows Long-Term Response In NSCLC
    Pfizer's BRAFTOVI + MEKTOVI Shows Long-Term Response In NSCLC

    14 Sep 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240913128678/en

    BUSINESSWIRE
    14 Sep 2024
    Share Share